Median survival in carcinoma pancreas after surgery and adjuvant therapy
12 months
22 months
32 months
44 months
After surgical resection and adjuvant therapy for pancreatic cancer, the Median survival is approximately 22 months, with 5 year survival of 15% to 20%. Most patients experience relapse of disease in the form of metastatic disease (85%) and less commonly, local recurrence (40%). In the absence of surgical resection, those with locally advanced disease who receive palliative chemotherapy may survive 10 to 12 months, whereas those with metastases rarely survive beyond 6 months Ref: Sabiston 20th edition Pgno :1547
G.I.T